Stanozolol 50 mg/ml injection

Chemical name:

17α-Methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]pyrazole

Anabolic activity index: 300%

Androgenic activity index: 30%

Pharmaceutical Classification: Androgen and Anabolic Steroid

General information:

Stanozolol is a17-alpha-alkylated anabolic steroid with good oral bioavailability. The hormone is then suspended in water; water is used as a carrying agent so that it may be injected into the body. Stanozolol does not aromatize and does not cause water retention. Stanozolol has been used for weight loss management in HIV patients with chronic obstructive pulmonary disease and has showed significant improvement in weight, body mass index, LBM, and muscle size. Stanozolol has been shown in vitro to significantly enhance collagen synthesis. A positive effect of stanazolol on wound healing in patients with non-healing wounds has also been demonstrated. Clinical studies show that the treatment with stanozolol during the induction phase of chemotherapy results in a positive effect on the duration of cancer-free remission.

Effective dose: 300 - 400 mg / week

Active half-life: 1 day

Package Form: 10ml multiple use vial.

Storage:

Store in a dry place, protected from direct light between 10-25 °C. Shake up the bottle before drawing into the syringe.